OBJECTIVES:Ready-to-use therapeutic food (RUTF) is the preferred treatment for uncomplicated severe acute malnutrition. It contains large amounts of linoleic acid and little α-linolenic acid, which may reduce the availability of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to the recovering child. A novel high-oleic RUTF (HO-RUTF) was developed with less linoleic acid to determine its effect on DHA and EPA status. METHODS: We conducted a prospective, randomized, double-blind clinical effectiveness trial treating rural Malawian children with severe acute malnutrition. Children were treated with either HO-RUTF or standard RUTF. Plasma phospholipid fatty acid status was measured on enrollment and after 4 weeks and compared between the 2 intervention groups. RESULTS: Among the 141 children enrolled, 48 of 71 receiving HO-RUTF and 50 of 70 receiving RUTF recovered. Plasma phospholipid samples were analyzed from 43 children consuming HO-RUTF and 35 children consuming RUTF. The change in DHA content during the first 4 weeks was +4% and -25% in the HO-RUTF and RUTF groups, respectively (P = 0.04). For EPA, the change in content was 63% and -24% in the HO-RUTF and RUTF groups, respectively (P < 0.001). For arachidonic acid, the change in content was -3% and 13% in the HO-RUTF and RUTF groups, respectively (P < 0.009). CONCLUSIONS: The changes in DHA and EPA seen in the children treated with HO-RUTF warrant further investigation because they suggest that HO-RUTF support improved polyunsaturated fatty acid status, necessary for neural development and recovery.
RCT Entities:
OBJECTIVES: Ready-to-use therapeutic food (RUTF) is the preferred treatment for uncomplicated severe acute malnutrition. It contains large amounts of linoleic acid and little α-linolenic acid, which may reduce the availability of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to the recovering child. A novel high-oleic RUTF (HO-RUTF) was developed with less linoleic acid to determine its effect on DHA and EPA status. METHODS: We conducted a prospective, randomized, double-blind clinical effectiveness trial treating rural Malawian children with severe acute malnutrition. Children were treated with either HO-RUTF or standard RUTF. Plasma phospholipid fatty acid status was measured on enrollment and after 4 weeks and compared between the 2 intervention groups. RESULTS: Among the 141 children enrolled, 48 of 71 receiving HO-RUTF and 50 of 70 receiving RUTF recovered. Plasma phospholipid samples were analyzed from 43 children consuming HO-RUTF and 35 children consuming RUTF. The change in DHA content during the first 4 weeks was +4% and -25% in the HO-RUTF and RUTF groups, respectively (P = 0.04). For EPA, the change in content was 63% and -24% in the HO-RUTF and RUTF groups, respectively (P < 0.001). For arachidonic acid, the change in content was -3% and 13% in the HO-RUTF and RUTF groups, respectively (P < 0.009). CONCLUSIONS: The changes in DHA and EPA seen in the children treated with HO-RUTF warrant further investigation because they suggest that HO-RUTF support improved polyunsaturated fatty acid status, necessary for neural development and recovery.
Authors: J Thomas Brenna; Norman Salem; Andrew J Sinclair; Stephen C Cunnane Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2009-03-09 Impact factor: 4.006
Authors: Long N Nguyen; Dongliang Ma; Guanghou Shui; Peiyan Wong; Amaury Cazenave-Gassiot; Xiaodong Zhang; Markus R Wenk; Eyleen L K Goh; David L Silver Journal: Nature Date: 2014-05-14 Impact factor: 49.962
Authors: Michael A Crawford; Yiqun Wang; David E Marsh; Mark R Johnson; Enitan Ogundipe; Ahamed Ibrahim; Hemalatha Rajkumar; S Kowsalya; Kumar S D Kothapalli; J T Brenna Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2022-04-06 Impact factor: 3.015
Authors: Zulfiqar A Bhutta; James A Berkley; Robert H J Bandsma; Marko Kerac; Indi Trehan; André Briend Journal: Nat Rev Dis Primers Date: 2017-09-21 Impact factor: 52.329
Authors: Kevin Stephenson; Meghan Callaghan-Gillespie; Kenneth Maleta; Minyanga Nkhoma; Matthews George; Hui Gyu Park; Reginald Lee; Iona Humphries-Cuff; R J Scott Lacombe; Donna R Wegner; Richard L Canfield; J Thomas Brenna; Mark J Manary Journal: Am J Clin Nutr Date: 2022-05-01 Impact factor: 8.472
Authors: J Thomas Brenna; Peter Akomo; Paluku Bahwere; James A Berkley; Philip C Calder; Kelsey D Jones; Lei Liu; Mark Manary; Indi Trehan; André Briend Journal: BMC Med Date: 2015-05-15 Impact factor: 8.775
Authors: Kelsey D J Jones; Rehema Ali; Maureen A Khasira; Dennis Odera; Annette L West; Grielof Koster; Peter Akomo; Alison W A Talbert; Victoria M Goss; Moses Ngari; Johnstone Thitiri; Said Ndoro; Miguel A Garcia Knight; Kenneth Omollo; Anne Ndungu; Musa M Mulongo; Paluku Bahwere; Greg Fegan; John O Warner; Anthony D Postle; Steve Collins; Philip C Calder; James A Berkley Journal: BMC Med Date: 2015-04-23 Impact factor: 8.775
Authors: K M Shahunja; Daniel C Sévin; Lindsay Kendall; Tahmeed Ahmed; Md Iqbal Hossain; Mustafa Mahfuz; Xinyi Zhu; Krishan Singh; Sunita Singh; Jonathan M Crowther; Rachel A Gibson; Gary L Darmstadt Journal: Nutr J Date: 2021-06-06 Impact factor: 3.271
Authors: Theresia Jumbe; Sarah S Comstock; Samantha L Hahn; William S Harris; Joyce Kinabo; Jenifer I Fenton Journal: PLoS One Date: 2016-05-03 Impact factor: 3.240